Clinicians frequently must face questions from patients or family members about how long a terminally ill patient has to live. Even for the experienced clinician, end-of-life (EOL) estimates are a ...
Uncertainty of prognosis is one reason patients with hematologic malignancies receive aggressive therapy near end of life more often than those with advanced solid tumors. It is unknown whether end-of ...
Kahlon and colleagues have published important data that relates frailty with 30-day outcomes after discharge from hospital, such as readmission to hospital and death.1 We are concerned that an ...